Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Rat dog micro-cap picks... -- Ignore unavailable to you. Want to Upgrade?

To: Bucky Katt who wrote (7417)	3/21/2002 12:10:13 PM
From: BW	Read Replies (1) \| Respond to of 48461

ASTM has a presentation on Monday, maybe they'll unleash some kewl news? Aastrom Biosciences Inc. Internet Event Alert (Nasdaq: ASTM chart, msgs) New York Society of Security Analysts 6th Annual Health Care Conference Power Point Presentation Featuring: Michael S. Durski VP Finance & Administration and CFO Aastrom Biosciences, Inc. ANN ARBOR, Mich., Mar 21, 2002 /PRNewswire-FirstCall via COMTEX/ -- Login and learn about Aastrom's: * Leadership in the development of proprietary cell therapeutics for medical treatment * Development plans for solid tissue regeneration programs, including osteoporosis and bone grafting * CE Mark approved Dendricell(TM) products for use in dendritic cell vaccines for the treatment of cancer: * DC-I dendritic cell product for pure dendritic cell production, and * DCV-I dendritic cell product for antigen-loaded vaccine production * European marketing and commercialization activities * Two stem cell therapies with European CE Mark approval and in late-stage U.S. cancer trials LIVE PRESENTATION DATE: Monday, March 25, 2002 TIME: 12:00 Noon (Eastern Time)